Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Samia Mora, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Samia Mora and Nancy Cook.
Samia Mora
Connection Strength
2.579
Nancy Cook
  1. Habitual Fish Consumption, n-3 Fatty Acids, and Nuclear Magnetic Resonance Lipoprotein Subfractions in Women. J Am Heart Assoc. 2020 03 03; 9(5):e014963.
    View in: PubMed
    Score: 0.215
  2. Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL. J Clin Lipidol. 2020 Mar - Apr; 14(2):241-251.
    View in: PubMed
    Score: 0.215
  3. Effects of One Year of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Biomarkers of Systemic Inflammation in Older US Adults. Clin Chem. 2019 12; 65(12):1508-1521.
    View in: PubMed
    Score: 0.211
  4. Marine n-3 Fatty Acids and Vitamin D Supplementation and Primary Prevention. Reply. N Engl J Med. 2019 05 09; 380(19):1879-1880.
    View in: PubMed
    Score: 0.204
  5. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative. JAMA Intern Med. 2018 09 01; 178(9):1231-1240.
    View in: PubMed
    Score: 0.194
  6. Lipoprotein(a) and Cardiovascular Risk Prediction Among Women. J Am Coll Cardiol. 2018 07 17; 72(3):287-296.
    View in: PubMed
    Score: 0.192
  7. Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: The Women's Health Study. J Clin Lipidol. 2017 Sep - Oct; 11(5):1257-1267.e2.
    View in: PubMed
    Score: 0.179
  8. Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women. J Endocr Soc. 2017 Feb 01; 1(2):113-123.
    View in: PubMed
    Score: 0.173
  9. Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State. Clin Chem. 2015 Sep; 61(9):1156-63.
    View in: PubMed
    Score: 0.155
  10. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation. 2007 Nov 06; 116(19):2110-8.
    View in: PubMed
    Score: 0.091
  11. Diabetes Mellitus, Race, and Effects of Omega-3 Fatty Acids on Incidence of Heart Failure Hospitalization. JACC Heart Fail. 2022 Apr; 10(4):227-234.
    View in: PubMed
    Score: 0.062
  12. Association of modifiable lifestyle factors with plasma branched chain amino acid metabolites in women. J Nutr. 2022 Mar 08.
    View in: PubMed
    Score: 0.062
  13. Serum Vitamin D: Correlates of Baseline Concentration and Response to Supplementation in VITAL-DKD. J Clin Endocrinol Metab. 2022 01 18; 107(2):525-537.
    View in: PubMed
    Score: 0.061
  14. Association of Plasma Branched-Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women. Circ Genom Precis Med. 2021 08; 14(4):e003330.
    View in: PubMed
    Score: 0.059
  15. Effects of Vitamin D3 Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL). J Clin Endocrinol Metab. 2021 04 23; 106(5):1377-1388.
    View in: PubMed
    Score: 0.058
  16. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. JAMA. 2021 03 16; 325(11):1061-1073.
    View in: PubMed
    Score: 0.058
  17. Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA-3 TriaL (VITAL). J Bone Miner Res. 2020 05; 35(5):883-893.
    View in: PubMed
    Score: 0.054
  18. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence. Circ Res. 2020 01 03; 126(1):112-128.
    View in: PubMed
    Score: 0.053
  19. Supplementation With Vitamin D and Omega-3 Fatty Acids and Incidence of Heart Failure Hospitalization: VITAL-Heart Failure. Circulation. 2020 03 03; 141(9):784-786.
    View in: PubMed
    Score: 0.053
  20. Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vitamin D treatment. Contemp Clin Trials. 2019 12; 87:105854.
    View in: PubMed
    Score: 0.053
  21. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence. Circulation. 2018 11 20; 138(21):2330-2341.
    View in: PubMed
    Score: 0.049
  22. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. 2019 01 03; 380(1):33-44.
    View in: PubMed
    Score: 0.049
  23. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. N Engl J Med. 2019 01 03; 380(1):23-32.
    View in: PubMed
    Score: 0.049
  24. The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. Am Heart J. 2010 Dec; 160(6):1163-9.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.